Qlaris Bio
PrivateLast Round
Seed Round
Jun 12, 2026
Total Funding Raised
$49M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Qlaris Bio operates in Healthcare & Life Sciences and is based in Dedham, Massachusetts. Its latest recorded funding round was a Series B round in April 2024.
Qlaris Bio is a biotechnology company that develops innovative, first-in-class therapies for serious and debilitating ophthalmic diseases, with a primary focus on glaucoma and ocular hypertension.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qlaris Bio Comparables
Compare Qlaris Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Betaliq, Inc. | 83% | |
| Bayer AG | 82% | |
| TheratOcular Biotek | 76% |
For institutional investors. Book with your work email.
Qlaris Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 12, 2026 | ||||
| Series B | Apr 30, 2024 | ||||
| Series A | Aug 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Qlaris Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Leaf Venture Partners | Series B, Series A |
| abrdn Inc. | Series B |
| Mayo Clinic Ventures | Series B |
| Canaan Partners | Series B, Series A |
| Aberdeen | Series B |
| Mayo Clinic Ventures | Series B |
| Correlation Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 493% MoM, reaching 2.8K.
- Jun 12, 2026
Raised $4M in a Seed Round.
For institutional investors. Book with your work email.
Qlaris Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Qlaris Bio's valuation, stock price, and market status.
Is Qlaris Bio a public or private company?
Qlaris Bio is a private company.
What is the current stock price of Qlaris Bio?
Qlaris Bio is a private company, so its shares have no public market price. Caplight tracks Qlaris Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qlaris Bio worth (valuation)?
Valuation information for Qlaris Bio is not publicly available.
Can I buy Qlaris Bio stock?
Qlaris Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qlaris Bio's last funding round?
Qlaris Bio's most recent funding round was Seed Round on June 12, 2026.
Who are the main investors in Qlaris Bio?
Key investors in Qlaris Bio include New Leaf Venture Partners, Canaan Partners.
Will Qlaris Bio IPO soon?
No public IPO plans have been announced for Qlaris Bio.
How can I track Qlaris Bio secondary market activity?
Caplight tracks bids, offers, and trades in Qlaris Bio's shares on secondary markets.